mebendazole has been researched along with Clerambault Syndrome in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mittermayer, T | 1 |
| Cisárová, A | 1 |
| Carnická, A | 1 |
| Magyar, B | 1 |
| Maloveská, M | 1 |
| Schréter, I | 1 |
1 other study available for mebendazole and Clerambault Syndrome
| Article | Year |
|---|---|
[Acute trichinellosis with neurological and mental manifestations treated with mebendazol and corticoids (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Benzimidazoles; Central Nervous System Diseases; Female; Humans; Meb | 1979 |